ASBMB

The Shimadzu Research Medal

The Shimadzu Research Medal is awarded to an outstanding ASBMB member with no more than 15 years since the award of the PhD degree (or equivalent taking any career disruption into account) at the nominated deadline. The successful candidate will present the Shimadzu Medal Lecture at the annual ASBMB conference. Nominees must have been members of the Society for at least 2 years before the year in which the Medal nomination is to be considered. An honorarium is provided through the courtesy of Shimadzu.

To view a list of previous Shimadzu medallists please click here

Nomination Information
- All nominees should have been members of the ASBMB for a minimum of 2 years
- All nominations should include at least 2 proposers who should have been members of the ASBMB for a minimum of 2 years
- Proposers should prepare a nomination document to include all information detailed on the Shimadzu Research Medal Nomination Template. This document should be saved as a single PDF file ready to be uploaded as part of the online nomination form.

When you are ready to begin your nomination, please click the button below.

2025 Award Recipient

Si Ming Man

Australian National University

Si Ming completed a Bachelor of Medical Science (Hons I, University Medal) at UNSW Sydney. His interests in host– pathogen interaction inspired his move to the UK, where he completed his PhD at the University of Cambridge in 2013 under the supervision of Professor Clare Bryant. During his PhD, he studied macrophage responses to the foodborne pathogen Salmonella, generating two first-author publications in PNAS. With the support of an NHMRC RG Menzies Early Career Fellowship, Si Ming moved to Memphis Tennessee, USA, where he completed his postdoctoral training at St. Jude Children’s Research Hospital under the mentorship of Dr Thirumala-Devi Kanneganti. During this time, Si Ming and his colleagues identified a role for innate immune proteins in liberating microbial ligands to drive activation of innate immunity and unexpected roles of immune receptors in cancer, generating first-author publications in Cell (2015, 2016), Nature (2016) and Nature Immunology (2015).

Si Ming returned to Australia in 2017 to establish his lab at the John Curtin School of Medical Research, Australian National University. He is now a Professor, CSL Centenary Fellow and NHMRC Leader Fellow. His more recent research is focused on the molecular and biochemical mechanisms of inflammation, including how antimicrobial killer proteins destroy bacteria and reduce antimicrobial resistance (Nature Communications 2022 and EMBO Journal 2023), anti-cancer capabilities of immune proteins (Nature Immunology 2024, Science Advances 2024 and Nature Communications 2024), and immunity to toxins (Nature Microbiology 2019, Nature Communications 2020 and EMBO Reports 2023). Si Ming was named a Clarivate Highly Cited Researcher in 2020, 2022, 2023 and 2024. His research has been recognised with 27 prizes, including the Australian Academy of Science Gottschalk Medal in 2023, Frank Fenner Prize for Life Scientist of the Year in 2022, Prime Minister’s Prizes for Science in 2022 and the ASBMB Eppendorf Edman ECR Award in 2020.